newsfilter
← Latest News
GlobeNewswire·

Starling Oncology to Participate in Wells Fargo Healthcare Conference

  • Starling Oncology (NASDAQ: STLN) announced that CEO Dr. Daniel Virnich & CFO Rob Carter will attend the Wells Fargo Healthcare Conference in Boston on September 8, 2026.
  • The executives will participate in a fireside chat scheduled from 4:30–5:05 p.m. ET.
  • A webcast of the presentation will be available via the Investor Relations section of the company website.
  • Founded in 2007, Starling Oncology serves approximately 2.1 million patients across over 100 clinic locations in five states.
  • The company employs over 400 clinicians & provides specialized, value-based cancer care including clinical trials & transfusions.